A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are ...
GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...
Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...
Karla Robinson, MD and Medical Editor at GoodRx discusses how GLP-1 receptor agonists work and their benefits.
The FDA said this after conducting a preliminary evaluation earlier this year of the drug class following some reports of suicidality and self-harm with GLP-1 agonists, but didn't find evidence ...
A study led by Prof. ZHU Yingjie from the Shenzhen Institute of Advanced Technology revealed that neurons in the lateral ...
Viking Therapeutics' VK2735, a dual GLP-1/GIP receptor agonist, shows promising results ... Viking as a strong contender in the obesity drug market. VKTX's financial stability, with $942 million ...
Terns Pharmaceuticals’ decision to drop its liver disease ambitions may yet pay off, after the biotech posted phase 1 data ...
Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...